AI-powered voice analysis for non-invasive drug and alcohol intoxication detection.
About
MindBio Therapeutics develops and commercializes AI-powered health prediction technologies that transform human voice into actionable health intelligence. Their proprietary platform analyzes acoustic biomarkers in speech to detect drug and alcohol intoxication, with applications in both consumer and enterprise markets, particularly for safety-critical industries.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does MindBio Therapeutics do?
MindBio Therapeutics develops and commercializes AI-powered health prediction technologies that transform human voice into actionable health intelligence. Their proprietary platform analyzes acoustic biomarkers in speech to detect drug and alcohol intoxication, with applications in both consumer and enterprise markets, particularly for safety-critical industries.
How much funding has MindBio Therapeutics raised?
MindBio Therapeutics has raised a total of $2M in funding. The most recent round on record is Private Placement.
Where is MindBio Therapeutics headquartered?
MindBio Therapeutics is headquartered in Melbourne, Australia.
When was MindBio Therapeutics founded?
MindBio Therapeutics was founded in 2021.
What industry does MindBio Therapeutics operate in?
MindBio Therapeutics operates in HealthTech, MedTech, AI-Driven Drug Discovery, Clinical Trials, Mental Health Tech, Biotech.
Similar Startups